Verastem Oncology Inc. (VSTM) Starts Presentation at B. Riley Conference
Verastem Oncology (NASDAQ: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Verastem is driven by the strength, tenacity and courage of those battling cancer – single-minded in the resolve to deliver new therapies that not only keep cancer at bay but improve the lives of patients diagnosed with cancer. The company’s first FDA approved product is now available for the treatment of patients with certain types of indolent non-Hodgkin’s lymphoma (iNHL). Verastem’s pipeline comprises product candidates that seek to treat cancer by modulating the local…







